Stem cells & therapeutics
Building on the research undertaken into stem cell states and stem cells in disease, Institute researchers are using stem cells to model diseases in vitro and to generate new diagnostic and therapeutic approaches to deliver patient benefit.
Several investigators are developing first-in-human clinical trials of cellular therapies using stem cell derivatives, while others work on new diagnostic and prognostic approaches to improve patient outcomes.
Our group leaders work across different areas within the therapeutics theme, details listed below. More information on each researcher's specific area can be found on their group pages.
| Prof Roger Barker | Parkinson's and Huntington's disease |
| Dr Cédric Ghevaert | In vitro production of platelets for transfusion |
| Prof Brian Huntly | Leukaemia stem cell biology and leukaemogenesis |
| Prof Andrew McCaskie | Regenerative therapies for bone and cartilage repair |
| Dr Simón Méndez-Ferrer | Blood stem cell niches |
| Dr Sanjay Sinha | Vascular diseases |
| Professor George Vassiliou | Leukaemic haemopoietic stem cells |